🔴 Website 👉 https://u-s-news.com/
Telegram 👉 https://t.me/usnewscom_channel
FIRST ON THE DAILY SIGNAL—Josh and Erin Hawley’s new pro-family nonprofit is touting polling showing the majority of Americans believe society should provide pregnant women with better options than abortion.
The polling, conducted by OnMessage Inc. on behalf of the Love Life Initiative, showed that 84% of Americans agree that “many pregnant mothers face difficult economic circumstances, but as a society we should focus on providing them with better options than abortion.”
Missouri Republican Senator Josh Hawley and his wife Erin, an attorney at Alliance Defending Freedom, are launching a new conservative nonprofit called the Love Life Initiative, which will run pro-family national ad campaigns. The Hawleys conducted polling through OnMessage Inc. showing strong majorities value pro-life, pro-family policies.
Of those surveyed, 77% said they agree that “as a society, we should be working towards having as few abortions as possible.” Another 80% agreed, with 62% saying they strongly agree, that “there needs to be at least some point during pregnancy when we can all agree that a baby cannot be aborted, unless the life of the mother is at risk.”
“Most women have an abortion because of a lack of support,” Erin Hawley said in a statement to The Daily Signal. “We want to change that. We want to build a culture that is pro-life and pro-family, and we can do that by providing broader support for women in need.”
Overall, 88% of Americans said that family formation is important to them, with 60% saying that raising a family is essential to a meaningful life
“We believe there needs to be a strong voice advocating for life and making it easier to start a family,” Josh Hawley said in a statement to The Daily Signal. “That is fundamental to who we are as Americans and the future of our country. And it is how we will be judged as a society. This is a generational project, not just about the next election cycle.”
Love Life Initiative’s polling found that the majority of Americans oppose the Biden-era Food and Drug Administration’s decision to axe the in-person dispensing requirement on the abortion pill.
Without any introduction, 37% of those surveyed said that chemical abortion drugs that women can receive through the mail and take at home are safe, while 42% said they are unsafe.
After the pollster told the respondents that the FDA recently reduced its safety standards for these drugs, making them available through mail and allowing them to be taken without doctor supervision despite many women suffering complications, 64% said they oppose the FDA’s decision. That number includes 53% who say they strongly oppose the FDA’s decision, reaching majorities of opposition across party lines.
In April 2021, the Biden administration’s FDA stopped requiring that abortion drugs be dispensed to women in person, which allowed women to receive them through telehealth appointments and by mail. The FDA has not enforced the in-person dispensing requirement ever since.
The Ethics & Public Police Center study found that about 11% of women experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion. This has led to calls to reinstate the in-person dispensing requirement for mifepristone.
When asked in the Love Life Initiative survey about the FDA’s decision to reduce safeguards on the abortion pill, 54% said health and safety need to be top priorities, while 27% said abortions should become more accessible.
The Hawleys, who met while clerking for Chief Justice John Roberts in 2007 and are the parents of three children, have been fierce advocates for limiting the abortion pill. Erin Hawley was the head counsel in FDA v. Alliance for Hippocratic Medicine, where she unsuccessfully argued in front of the Supreme Court that the FDA’s removal of commonsense safeguards for abortion drugs was unlawful.
Josh Hawley has repeatedly pressed FDA Commissioner Dr. Marty Makary to do a safety review on mifepristone.
Hawley wrote a letter to Makary on Dec. 10 demanding answers after the commissioner declined to give The Daily Signal a time frame for his review on the abortion pill.
“Yesterday, in response to the latest reports, you said, ‘There has been an ongoing review of mifepristone. It’s actually required as part of a policy called REMS,’” Hawley wrote, linking to The Daily Signal interview. “But that is not what you promised. You promised a new and comprehensive study taking account of all available safety data, not the standard monitoring FDA already performs for countless drugs.”
Makary told The Daily Signal last week that the review of the abortion drug mifepristone is in the “data acquisition phase,” following a Bloomberg report saying he is delaying the process until after midterms.
“We do an ongoing review, but we’re also engaging in a robust study that can serve to validate or not validate other numbers that have been put out there in the literature,” the FDA chief said.
[Editor’s note: This story originally was published by The Daily Signal.]
This content is courtesy of, and owned and copyrighted by, https://www.wnd.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.